Amedisys
AMED
AMED was delisted on the 14th of August, 2025.
152 hedge funds and large institutions have $1.7B invested in Amedisys in 2017 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 57 increasing their positions, 58 reducing their positions, and 22 closing their positions.
25% more call options, than puts
Call options by funds: $3.94M | Put options by funds: $3.15M
22% more capital invested
Capital invested by funds: $1.39B → $1.7B (+$310M)
1.92% more ownership
Funds ownership: 96.84% → 98.76% (+1.9%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2% less repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 58
5% less funds holding
Funds holding: 160 → 152 (-8)
14% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 22
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$262M |
| 2 |
American Century Companies
Kansas City,
Missouri
|
+$34.2M |
| 3 |
Bank of New York Mellon
New York
|
+$20.7M |
| 4 |
MPAM
Monarch Partners Asset Management
Boston,
Massachusetts
|
+$8.39M |
| 5 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$8.06M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PC
Polar Capital
London,
United Kingdom
|
-$16.5M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
-$12.9M |
| 3 |
Wells Fargo
San Francisco,
California
|
-$11.4M |
| 4 |
Renaissance Technologies
New York
|
-$11.3M |
| 5 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
-$8.98M |
AMED Hedge Fund Activity: Q1 2017 in Review
152 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q1 2017, worth a combined $1.7B — up 22% from $1.39B a quarter earlier.
Sellers outnumbered buyers: 22 funds closed out of AMED and 19 opened new positions — a net loss of 3 holders — while 58 trimmed existing stakes and 57 added.
The largest buyer was BlackRock, adding an estimated $262M. The largest seller was Polar Capital, exiting entirely with an estimated $16.5M sold.
- 152 institutional investors held Amedisys (AMED) as of Q1 2017, down from 160 in Q4 2016.
- Funds reported $1.7B of Amedisys stock for Q1 2017, up 22% quarter-over-quarter.
- 19 funds opened new Amedisys positions in Q1 2017 and 22 closed out, a net change of -3 holders.
- The largest Amedisys buyer in Q1 2017 was BlackRock, an estimated $262M added.
- The largest Amedisys seller in Q1 2017 was Polar Capital, an estimated $16.5M sold.
Based on aggregated 13F filings for Q1 2017.